Uncategorized

Editor’s pick: Stylus Medicine

Published

on

Nature Biotechnology, Published online: 16 July 2026; doi:10.1038/s41587-026-03225-x

Each year, Nature Biotechnology highlights companies that received sizeable early-stage funding in the previous year. Stylus Medicine is engineering novel recombinases for in vivo CAR T cell cancer therapy.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version